Analyst Ratings for Enhabit Home Health & Hospice (EHAB)
EHAB Rating Summary
EHAB Price Target Summary
- Highest: $13.80 (Jefferies)
- Lowest: $13.80 (Jefferies)
- Average: $13.80
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$13.80 (0%)
* Over Last 12-Mos
Rating Score: 0.8 / 10
Percentile Rank: 6%
Avg. $ Target:
$13.80 (0%)
* Over Last 12-Mos
Rating Score: 0.8 / 10
Percentile Rank: 6%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2026 | TD Cowen | Ryan Langston | Downgrade | Hold (Buy) |
13.80 (12.00) |
13.61 (13.80) |
1.4% | Details |
| 2/24/2026 | UBS | AJ Rice | Downgrade | Neutral (Buy) |
13.80 (12.00) |
11.09 (13.80) |
24.44% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
